JUDGE REFUSES TO CREATE CALIFORNIA SUBCLASS IN LIPITOR ANTITRUST CASE

摘要

A federal judge has refused to create a California subclass within a nationwide proposed class action accusing Pfizer Inc of obtaining a fraudulent patent and conspiring with generic drugmaker Ranbaxy Inc to delay sales of generic versions of its cholesterol drug Lipitor.